Literature DB >> 19937165

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy.

Stacey M Parker1, Horatiu Olteanu2, Peter VanTuinen2, Colleen A Lawton3, Christopher J Schultz3, Kathleen K Christians4, Timothy S Fenske5.   

Abstract

Dual translocated (or "dual hit") lymphomas are highly aggressive B cell neoplasms associated with an extremely poor prognosis. The optimal treatment for these lymphomas remains undefined. We present two cases of follicular lymphoma with transformation to Burkitt-like lymphoma. In both cases dual translocations involving both the bcl-2 and c-myc loci were present. Each patient underwent intensive induction immunochemotherapy followed by autologous stem cell transplantation and radiation therapy. The first patient received post-transplant mediastinal radiation and developed recurrence in multiple areas outside of the radiation field. The second patient received total body irradiation as part of the conditioning regimen, and is without recurrence 18 months after transplant, and 24 months after diagnosis of the dual translocated lymphoma. We review dual translocation B cell lymphoma in the setting of transformation from follicular lymphoma, and suggest a potential role for total body irradiation in the management of this highly aggressive non-Hodgkin lymphoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937165     DOI: 10.1007/s12185-009-0444-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

1.  Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.

Authors:  Rebecca F McClure; Ellen D Remstein; William R Macon; Gordon W Dewald; Thomas M Habermann; Antje Hoering; Paul J Kurtin
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

Review 2.  Molecular biology of Burkitt's lymphoma.

Authors:  J L Hecht; J C Aster
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

3.  Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.

Authors:  Nyla A Heerema; Susana C Raimondi; James R Anderson; Jaclyn Biegel; Bruce M Camitta; Linda D Cooley; Paul S Gaynon; Betsy Hirsch; R Ellen Magenis; Loris McGavran; Shivanand Patil; Mark J Pettenati; Jeanette Pullen; Kathleen Rao; Diane Roulston; Nancy R Schneider; Jonathan J Shuster; Warren Sanger; Maxine J Sutcliffe; Peter van Tuinen; Michael S Watson; Andrew J Carroll
Journal:  Genes Chromosomes Cancer       Date:  2007-07       Impact factor: 5.006

Review 4.  Highly aggressive lymphomas in adults.

Authors:  John W Sweetenham
Journal:  Hematol Oncol Clin North Am       Date:  2008-10       Impact factor: 3.722

Review 5.  Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma.

Authors:  A D Zelenetz; P Hamlin; T Kewalramani; J Yahalom; S Nimer; C H Moskowitz
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

Review 6.  Follicular lymphoma with a burkitt translocation--predictor of an aggressive clinical course: a case report and review of the literature.

Authors:  Peter M Voorhees; Kathryn A Carder; Scott V Smith; Lanier H Ayscue; Kathleen W Rao; Cherie H Dunphy
Journal:  Arch Pathol Lab Med       Date:  2004-02       Impact factor: 5.534

Review 7.  Adult Burkitt leukemia and lymphoma.

Authors:  Kristie A Blum; Gerard Lozanski; John C Byrd
Journal:  Blood       Date:  2004-07-20       Impact factor: 22.113

8.  Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Authors:  Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

9.  Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations.

Authors:  N Niitsu; M Okamoto; I Miura; M Hirano
Journal:  Leukemia       Date:  2009-01-08       Impact factor: 11.528

10.  Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).

Authors:  John A Thompson; Richard I Fisher; Michael Leblanc; Stephen J Forman; Oliver W Press; Joseph M Unger; Auayporn P Nademanee; Patrick J Stiff; Stephen H Petersdorf; Alexander Fefer
Journal:  Blood       Date:  2008-02-06       Impact factor: 22.113

View more
  4 in total

1.  A Case of Advanced Primary Thyroid Double-Hit B Cell Lymphoma in Which Complete Remission has been Maintained After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Performed During the Second Remission, with a Review of the Literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomohiro Sawada; Yasunori Ohta; Norio Komatsu; Masaaki Noguchi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

Review 2.  Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.

Authors:  Xiaoxiao Xu; Le Zhang; Yafei Wang; Qing Zhang; Lianyu Zhang; Baocun Sun; Yizhuo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

Review 3.  Atypical Burkitt's lymphoma transforming from follicular lymphoma.

Authors:  Yu Y Hwang; Florence Loong; Lap P Chung; Chor S Chim
Journal:  Diagn Pathol       Date:  2011-07-08       Impact factor: 2.644

4.  Transformation of follicular lymphoma to double hit B-cell lymphoma causing hypercalcemia in a 69-year-old female: a case report and review of the literature.

Authors:  Sakshi Kapur; Miles B Levin
Journal:  Case Rep Hematol       Date:  2014-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.